These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Wagstaff AJ; Bryson HM Drugs; 1994 Aug; 48(2):199-226. PubMed ID: 7527325 [TBL] [Abstract][Full Text] [Related]
24. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Jabs DA Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191 [TBL] [Abstract][Full Text] [Related]
25. Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections. Jacobson MA Adv Exp Med Biol; 1996; 394():85-92. PubMed ID: 8815712 [No Abstract] [Full Text] [Related]
26. Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet. Keijer WJ; Burger DM; Neuteboom GH; Vrooland JL; Meenhorst PL; Koks CH; Beijnen JH Pharm World Sci; 1993 Apr; 15(2):56-67. PubMed ID: 8387852 [TBL] [Abstract][Full Text] [Related]
27. Is combination antiviral therapy for CMV superior to monotherapy? Drew WL J Clin Virol; 2006 Apr; 35(4):485-8. PubMed ID: 16387546 [TBL] [Abstract][Full Text] [Related]
28. Current management of cytomegalovirus disease in patients with AIDS. Jacobson MA AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543 [TBL] [Abstract][Full Text] [Related]
29. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease. Balfour HH Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708 [TBL] [Abstract][Full Text] [Related]
30. New treatment options for CMV retinitis in AIDS. Lalezari JP Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896 [No Abstract] [Full Text] [Related]
32. Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS. Lee TA; Sullivan SD; Veenstra DL; Ramsey SD; Steger PJ; Malinverni R; Pleil AM; Williamson T Pharmacoeconomics; 2001; 19(5 Pt 2):535-50. PubMed ID: 11465299 [TBL] [Abstract][Full Text] [Related]
33. Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches. Fu L; Santhanakrishnan K; Al-Aloul M; Jones NP; Steeples LR Ocul Immunol Inflamm; 2020 Oct; 28(7):1152-1158. PubMed ID: 31621449 [No Abstract] [Full Text] [Related]
34. A foveal-sparing pattern of cytomegalovirus retinitis in the acquired immunodeficiency syndrome. Luckie AP; Ai E Aust N Z J Ophthalmol; 1996 Feb; 24(1):53-9. PubMed ID: 8743006 [TBL] [Abstract][Full Text] [Related]
35. Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. Anders HJ; Weiss N; Bogner JR; Goebel FD J Infect; 1998 Jan; 36(1):29-33. PubMed ID: 9515665 [TBL] [Abstract][Full Text] [Related]
36. Management of cytomegalovirus retinitis in AIDS. Phillips P Eur J Clin Microbiol Infect Dis; 2000 Aug; 19(8):571-84. PubMed ID: 11014619 [No Abstract] [Full Text] [Related]
37. Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents. Vadlapudi AD; Vadlapatla RK; Mitra AK Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):8-18. PubMed ID: 22044356 [TBL] [Abstract][Full Text] [Related]
38. Clinical use of ganciclovir for cytomegalovirus infection and the development of drug resistance. Drew WL J Acquir Immune Defic Syndr (1988); 1991; 4 Suppl 1():S42-6. PubMed ID: 1848621 [TBL] [Abstract][Full Text] [Related]
39. [Active antiviral agents against human cytomegalovirus and their use in pediatrics]. Mazeron MC; Alain S Arch Pediatr; 1996; 3 Suppl 1():309s-311s. PubMed ID: 8796051 [No Abstract] [Full Text] [Related]